# Protocol for Improvement of Therapy With Warfarin

Study · id `cardio:ct-nct06789588` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT06789588](<https://clinicaltrials.gov/study/NCT06789588>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT06789588

Browse, organ or system: Heart  
Browse, condition area: Stroke; Heart rhythm problems  

## In plain language

A phase 3 trial registered on ClinicalTrials.gov. The registry status is enrolling by invitation. It plans to enroll 700 participants.

## Technical summary

Registry record NCT06789588. Randomized; single masking; primary purpose treatment. Start 2024-10-21 (actual); primary completion 2026-07 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose treatment
- Phase: Phase 3
- Enrolled: 700 participants (planned count; ClinicalTrials.gov record NCT06789588, source copy `cardio:ctgov-nct06789588-2025-06-04`, retrieved 2026-10-26)
- Started: 2024-10-21 (actual) (ClinicalTrials.gov record NCT06789588, source copy `cardio:ctgov-nct06789588-2025-06-04`, retrieved 2026-10-26)
- Primary completion: 2026-07 (anticipated) (ClinicalTrials.gov record NCT06789588, source copy `cardio:ctgov-nct06789588-2025-06-04`, retrieved 2026-10-26)
- Completion: 2027-07 (anticipated) (ClinicalTrials.gov record NCT06789588, source copy `cardio:ctgov-nct06789588-2025-06-04`, retrieved 2026-10-26)
- Countries: Brazil (ClinicalTrials.gov record NCT06789588, source copy `cardio:ctgov-nct06789588-2025-06-04`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "ENROLLING\_BY\_INVITATION" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct06789588-2025-06-04`, retrieved 2026-10-26)

## The registry's words

- Brief title: Protocol for Improvement of Therapy With Warfarin
- Acronym: WARFALGORIT
- Condition: Atrial Fibrillation (AF)
- Intervention (Drug): pharmacogenetic algorithm
- Intervention (Drug): Clinical treatment
- Lead sponsor: University of Pernambuco
- Lead sponsor class: OTHER
- Collaborator: Universidade Federal de Pernambuco
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Arrhythmia (heart rhythm problems) (`cardio:arrhythmia`)
- Registry condition terms include this condition: Atrial fibrillation (AF) (`cardio:atrial-fibrillation`)

## Provenance

Content hash: 4fe6a73b69f35d88bc951391050b464b7e4276cdbd97a6a1bcd9150d78061d86
Last substantive edit: 2026-10-26
Evidence last checked: Not recorded
